Home » Newsletters » BioWorld

BioWorld

Nov. 15, 2000

View Archived Issues

Procyon, Biovation Enter Deal On ANA Therapeutic Antibodies

Xenogen Acquires DNX In Move That Adds Transgenic Capability

Merck Scientists Fabricate PSA Compound To Treat Testosterone- Refractory End-Stage Malignancy

Rules Changing, Money Flowing For Collaborations With Japanese

Other News To Note

Pharmacia Returns Rights To Cancer Vaccine To Epimmune

Epigenomics' $24M Round Will Fund Creation Of U.S. Presence

Adolor Finally Gets IPO Through, Raises $90M In Tough Conditions